Otto, Mutairee E.

HRN: 24-89-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
OXACILLIN 500MG (VIAL)
04/23/2024
04/29/2024
IV
150mg
Q6
Staphylococcal Infection
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes